Inactive Instrument

Real Nutriceutical Group Limited

2010

KYG7410S1003

Real Nutriceutical Group Limited Does Not Recommend Final Dividend for the Year Ended December 31, 2016

March 30, 2017 at 03:48 pm

The Board of Real Nutriceutical Group Limited does not recommend the payment of a final dividend for the year ended December 31, 2016 compared to 4.2 HK cents paid a year ago.

Latest news about Real Nutriceutical Group Limited

Real Nutriceutical Group Limited Appoints Kwan Sai Bun, Daniels as an Authorised Representative	03/10/19	CI
Real Nutriceutical Group Limited Receives Two Garnishee Orders Nisi	16/09/19	CI
Real Nutriceutical Group Limited Announces Tendered Resignation of Poon Yick Pang as Company Secretary	21/03/19	CI
Real Nutriceutical Group Limited Announces Board Appointments	10/01/19	CI
Real Nutriceutical Group Limited Announces Executive Changes	19/12/18	CI
Real Nutriceutical Group Limited Announces Board Changes	26/11/18	CI
Real Nutriceutical Group Limited Recommends Special Dividend	23/11/18	CI
Real Nutriceutical Group Limited Announces Consolidated Earnings Results for the Year Ended December 31, 2017	29/03/18	CI
Real Nutriceutical Group Limited Announces Board Changes, Effective 1 April 2018	29/03/18	CI
Real Nutriceutical Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended December 31, 2017	22/03/18	CI
Shanghai Heyu Medical Technology Co., Ltd completed the acquisition of Anhui Province Shuangke Pharmaceutical Company Limited, Nanjing Ruinian Best Pharmaceutical Co., Ltd. and Wuxi Ruinian Pharmaceutical Company Limited from Real Nutriceutical Group Limited.	07/03/18	CI
Real Nutriceutical Group Limited cancelled the acquisition of Major Express Group Limited from Tseng Hui-che.	30/12/17	CI
Shanghai Heyu Medical Technology Co., Ltd entered into the sale and purchase agreement to acquire Anhui Province Shuangke Pharmaceutical Company Limited, Nanjing Ruinian Best Pharmaceutical Co., Ltd. and Wuxi Ruinian Pharmaceutical Company Limited from Real Nutriceutical Group Limited for CNY 15 million.	21/12/17	CI
Real Nutriceutical Group Limited Announces Board Changes, Effect from October 12, 2017	04/10/17	CI
Real Nutriceutical Group Limited Announces Unaudited Consolidated Cash Flow Results for the Six Months Ended June 30, 2017	20/09/17	CI
Real Nutriceutical Group Limited(SEHK:2010) dropped from S&P Global BMI Index	18/09/17	CI
Real Nutriceutical Group Limited Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017	30/08/17	CI
Real Nutriceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2017	22/08/17	CI
Real Nutriceutical Group Limited agreed to acquire Major Express Group Limited from Tseng Hui-che for CNY 1.5 billion.	18/04/17	CI
Real Nutriceutical Group Limited Does Not Recommend Final Dividend for the Year Ended December 31, 2016	30/03/17	CI
Real Nutriceutical Group Limited Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2016	30/03/17	CI
Real Nutriceutical Group Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2016	17/03/17	CI
Real Nutriceutical Group Limited Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2016	22/09/16	CI
Tranche Update on Real Nutriceutical Group Limited's Equity Buyback Plan announced on January 14, 2016.	22/09/16	CI
Real Nutriceutical Group Limited Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2016	30/08/16	CI

Chart Real Nutriceutical Group Limited

Duration

Period

More charts

Real Nutriceutical Group Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of health and nutritional supplements. The Company operates through three segments. Health and Nutritional Supplements segment is engaged in the manufacture and sales of health and nutritional supplements. Its products include amino acids products, nutrient products and imported products, among others. Health Drinks segment is engaged in the manufacture and sales of health drinks. Its products include herbal tea products and amino acid drinks. Pharmaceutical Products segment is engaged in the manufacture and sales of pharmaceutical products. Its main products include eye drops and antineoplastic drugs.

Sector

Food Processing

More about the company

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
ZHEJIANG NHU COMPANY LTD.	+16.86%	8.43B
BELLRING BRANDS, INC.	+3.57%	7.49B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+4.89%	6.23B
THE SIMPLY GOOD FOODS COMPANY	-5.23%	3.75B
BYHEALTH CO., LTD	-6.58%	3.75B
XIAMEN KINGDOMWAY GROUP COMPANY	-3.55%	1.33B
HERBALIFE LTD.	-28.64%	1.09B
SIRIO PHARMA CO., LTD.	+18.12%	1.02B
USANA HEALTH SCIENCES, INC.	-8.60%	933M

Special Foods & Wellbeing Products